What You Should Know:
- Today, Deep Lens and Cardinal Health announced a strategic collaboration that will integrate Deep Lens’ AI-based clinical trial matching solution, VIPER, into community-based oncology practices throughout the Cardinal network. VIPER will be a part of Cardinal Health’s new Navista advanced suite of technology solutions designed to help oncologists improve outcomes, provide high quality care at the best possible cost and select the right care plan at the onset of
Read More
Clinical Trials | News, Analysis, Insights - HIT Consultant
Janssen Taps Komodo Health to Optimize Site Selection and Patient Recruitment for Clinical Trials
What You Should Know:
- Komodo Health today announced a new client engagement with Janssen solidifying its role as the leading life sciences patient data analytics platform. Janssen Research & Development, LLC (Janssen) will be using Komodo's real-world data and AI software to accelerate clinical development. Janssen plans to use Komodo's services to optimize feasibility, site selection and patient recruitment for clinical trials, ultimately driving higher throughput for
Read More
To Advance Health Equity, Put Real-World Cancer Data to Work
Despite decades of scientific progress against cancer, access to treatment remains highly unequal. Some of the reasons — like institutional racism and poverty — are a reflection of our broader society. Other inequities may go unrecognized but are no less damaging. People with underlying health conditions, for example, may be excluded from clinical trials, preventing them from accessing leading-edge treatments and limiting the evidence available to guide their care.
With multiple drivers of
Read More
NeoGenomics Acquires Precision Oncology Platform Trapelo Health for $65M
What You Should Know:
- NeoGenomics, Inc., a provider of cancer-focused genetic testing services and global oncology contract research services announced it has reached an agreement to acquire precision oncology platform Trapelo Health for $65M. The agreement purchase price of $65 million, consists of $35 million in cash on hand and $30 million in NeoGenomics common stock and is expected to close in April 2021.
- Trapelo Health offers a first-of-its-kind, interoperable, decision-support
Read More
AppliedVR Lands $29M for VR Platform to Treat Chronic Pain
What You Should Know:
- AppliedVR, a Los Angeles, CA-based company advancing the next generation of digital medicine, today announced $29 million in Series A funding, bringing its total funds raised to date to $35 million. The round, which includes key investors F-Prime Capital, JAZZ Venture Partners, Sway Ventures, GSR Ventures, Magnetic Ventures and Cedars-Sinai, will fuel the company’s growth as it pursues full FDA approval over the next year.
- Founded in 2015, AppliedVR provides
Read More
BioIntelliSense Partners with Leukemia & Lymphoma Society for Continuous Monitoring in Clinical Trials
What You Should Know:
-BioIntelliSense announced it has entered into a strategic partnership with The Leukemia & Lymphoma Society (LLS) to incorporate the BioSticker™ platform in clinical trials of hematological cancer patients.
- The LLS clinical trials will include use of the BioSticker medical device for the continuous collection of vital sign and physiological data which includes temperature, heart rate, respiratory rate at rest, activity level and body position. The BioSticker
Read More
Data-Driven Future: Impact of Machine Learning on Diabetes Management
“Information technology and business are becoming inextricably interwoven. I don't think anybody can talk meaningfully about one without the talking about the other” – Bill Gates wrote this in 1999 and, nowadays, the same can certainly be said about information technology and healthcare.
The ability to collect, analyze, and use data is becoming ubiquitous with many of healthcare’s most exciting advancements. Whether it’s Google’s DeepMind using artificial intelligence (AI) to help
Read More
UK Launches World’s First COVID-19 Human Challenge Study
What You Should Know:
- This week, the United Kingdom (UK) will be the first country in the world to run a COVID-19 human challenge study, following approval from the UK’s clinical trials ethics body.
- First Covid-19 human challenge study will begin within a month, after receiving ethics approval in the same week the UK hits target of offering first dose to 15 million people.
- Researchers call on healthy young people to volunteer for the study, which will play a key role in developing
Read More
Seed Health Acquires Auggi’s Stool Recognition AI Tech & Algorithms
What You Should Know:
- Seed Healthv, a microbial sciences company, announced the acquisition of Auggi, a digital health company with a suite of artificial intelligence and machine learning technologies to track and analyze digestive health.
- As part of the acquisition, Seed Health will acquire Auggi's technology assets, including its AI algorithm for real-time Bristol stool typing, the world's largest stool image database, and a mobile monitoring application for clinical research.
-
Read More
Why Cancer Registries are Part of America’s Fight for Racial Equality
According to a 2019 study in the Proceedings of the National Academy of Sciences, one in 1,000 Black males can expect to die at the hands of the police. Black males were also 2.5 times more likely to die during an encounter with police than white males. For some, those figures are staggering. For many others, they are reminders of the racial disparities that have existed for far too long in this country.
So, in 2020, when recent events have brought racial injustice back into the national
Read More
